MAP2K3 and prostate carcinoma: In prostate cancer, Misra and Pizzo reported that the activated cell surface protein BiP (GRP78) supports proliferation through the MKK3-p38MAPK/α2-macroglobulin inhibitor protein (α2M*) crosstalk in 1-LN cells.